Annals of Oncology

1

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis

Juo, Y. Y., Johnston, F. M., Zhang, D. Y., Juo, H. H., Wang, H., Pappou, E. P., Yu, T., Easwaran, H., Baylin, S., van Engeland, M., Ahuja, N.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 225 KB

english, 2014

2

A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma

Mian, M., Marcheselli, L., Rossi, A., Visco, C., Chiappella, A., Volpetti, S., Zaja, F., Mondello, P., Fiegl, M., Billio, A., Federico, M., Luminari, S., Rambaldi, A., Cortelazzo, S.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 374 KB

english, 2014

3

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

Piccart, M., Hortobagyi, G. N., Campone, M., Pritchard, K. I., Lebrun, F., Ito, Y., Noguchi, S., Perez, A., Rugo, H. S., Deleu, I., Burris, H. A., Provencher, L., Neven, P., Gnant, M., Shtivelband, M.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 142 KB

english, 2014

4

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Zhou, Q., Cheng, Y., Yang, J.- J., Zhao, M.- F., Zhang, L., Zhang, X.- C., Chen, Z.- H., Yan, H.- H., Song, Y., Chen, J.- H., Feng, W.- N., Xu, C.- R., Wang, Z., Chen, H.- J., Zhong, W.- Z., Liu, Y.-

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 228 KB

english, 2014

5

Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death

Birch, S. E., Kench, J. G., Takano, E., Chan, P., Chan, A.- L., Chiam, K., Veillard, A.- S., Stricker, P., Haupt, S., Haupt, Y., Horvath, L., Fox, S. B.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 388 KB

english, 2014

6

Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma

Zhang, Q., Ji, X. W., Hou, X. M., Lu, F. M., Du, Y., Yin, J. H., Sun, X. Y., Deng, Y., Zhao, J., Han, X., Yang, G. S., Zhang, H. W., Chen, X. M., Shen, H. B., Wang, H. Y., Cao, G. W.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 213 KB

english, 2014

7

PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics

Massi, D., Brusa, D., Merelli, B., Ciano, M., Audrito, V., Serra, S., Buonincontri, R., Baroni, G., Nassini, R., Minocci, D., Cattaneo, L., Tamborini, E., Carobbio, A., Rulli, E., Deaglio, S., Mandala

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 917 KB

english, 2014

8

REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours

Levy, C., Allouache, D., Lacroix, J., Dugue, A. E., Supiot, S., Campone, M., Mahe, M., Kichou, S., Leheurteur, M., Hanzen, C., Dieras, V., Kirova, Y., Campana, F., Le Rhun, E., Gras, L., Bachelot, T.,

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 227 KB

english, 2014

9

Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?

Ignatiadis, M., Dawson, S.- J.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 1.19 MB

english, 2014

10

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

Blons, H., Emile, J. F., Le Malicot, K., Julie, C., Zaanan, A., Tabernero, J., Mini, E., Folprecht, G., Van Laethem, J. L., Thaler, J., Bridgewater, J., Norgard-Petersen, L., Van Cutsem, E., Lepage, C

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 229 KB

english, 2014

11

SIE-SIES-GITMO Guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias

Corradini, P., Marchetti, M., Barosi, G., Billio, A., Gallamini, A., Pileri, S., Pimpinelli, N., Rossi, G., Zinzani, P. L., Tura, S.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 158 KB

english, 2014

12

Focal or combined modality for the management of brain metastasis: did high tech radiotherapy superseded drug-radiotherapy combination?

Deutsch, E., Dhermain, F., Chargari, C.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 54 KB

english, 2014

13

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)

von Minckwitz, G., Loibl, S., Untch, M., Eidtmann, H., Rezai, M., Fasching, P. A., Tesch, H., Eggemann, H., Schrader, I., Kittel, K., Hanusch, C., Huober, J., Solbach, C., Jackisch, C., Kunz, G., Bloh

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 332 KB

english, 2014

14

Cognitive function and fatigue after diagnosis of colorectal cancer

Vardy, J., Dhillon, H. M., Pond, G. R., Rourke, S. B., Xu, W., Dodd, A., Renton, C., Park, A., Bekele, T., Ringash, J., Zhang, H., Burkes, R., Clarke, S. J., Tannock, I. F.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 195 KB

english, 2014

15

Glucocorticoid prescriptions and breast cancer recurrence: a Danish nationwide prospective cohort study

Lietzen, L. W., Ahern, T., Christiansen, P., Jensen, A. B., Sorensen, H. T., Lash, T. L., Cronin-Fenton, D. P.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 111 KB

english, 2014

16

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials

Le Cesne, A., Ouali, M., Leahy, M. G., Santoro, A., Hoekstra, H. J., Hohenberger, P., Van Coevorden, F., Rutkowski, P., Van Hoesel, R., Verweij, J., Bonvalot, S., Steward, W. P., Gronchi, A., Hogendoo

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 225 KB

english, 2014

17

Reply to the letter to the editor 'Second-line chemotherapy in advanced biliary cancer: the present now will later be past' by Vivaldi et al.

Lamarca, A., Hubner, R. A., Ryder, W. D., Valle, J. W.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 44 KB

english, 2014

18

Prioritizing targets for precision cancer medicine

Andre, F., Mardis, E., Salm, M., Soria, J.- C., Siu, L. L., Swanton, C.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 295 KB

english, 2014

19

The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer

Meisel, J. L., Hyman, D. M., Garg, K., Zhou, Q., Dao, F., Bisogna, M., Gao, J., Schultz, N. D., Grisham, R. N., Phillips, M., Iasonos, A., Kauff, N. D., Levine, D. A., Soslow, R. A., Spriggs, D. R.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 439 KB

english, 2014

20

Second-line chemotherapy in advanced biliary cancer: a systematic review

Lamarca, A., Hubner, R. A., David Ryder, W., Valle, J. W.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 261 KB

english, 2014

21

Second-line chemotherapy in advanced biliary cancer: the present now will later be past

Vivaldi, C., Fornaro, L., Cereda, S., Aprile, G., Santini, D., Silvestris, N., Lonardi, S., Leone, F., Milella, M., Brandi, G., Vasile, E.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 114 KB

english, 2014

22

Editorial board

Journal:

Annals of Oncology

Year:

2014

File:

PDF, 267 KB

2014

23

Volume 25; Issue 12

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis

A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death

Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma

PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics

REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours

Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

SIE-SIES-GITMO Guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias

Focal or combined modality for the management of brain metastasis: did high tech radiotherapy superseded drug-radiotherapy combination?

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)

Cognitive function and fatigue after diagnosis of colorectal cancer

Glucocorticoid prescriptions and breast cancer recurrence: a Danish nationwide prospective cohort study

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials

Reply to the letter to the editor 'Second-line chemotherapy in advanced biliary cancer: the present now will later be past' by Vivaldi et al.

Prioritizing targets for precision cancer medicine

The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer

Second-line chemotherapy in advanced biliary cancer: a systematic review

Second-line chemotherapy in advanced biliary cancer: the present now will later be past

Editorial board

Table of Contents